Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alcoholism

Free Subscription Articles published in Am J Drug Alcohol Abuse Retrieve available abstracts of 48 articles: HTML format

Single Articles

February 2026
1. ASLAN M, Paltun SC, Ergelen M, Durmus Z, et al
   Peripheral inflammatory biomarkers associated with alcohol withdrawal delirium in alcohol use disorder: a cross-sectional study.
   Am J Drug Alcohol Abuse. 2026 Feb 11:1-12. doi: 10.1080/00952990.2026.2619091.
   PubMed     Abstract available
   
   
   January 2026
2. NIGATU YT, Boak A, Imtiaz S, Hamilton HA, et al
   Age, period and cohort effects on heavy episodic drinking among adolescents in Ontario, Canada: 1999-2023.
   Am J Drug Alcohol Abuse. 2026;52:42-51.
   PubMed     Abstract available
   
   
   
3. LORRAI I, Maccioni R, Marquez Gaytan J, Yin SC, et al
   Effect of saikosaponin A, one of the main bioactive triterpenoids of Bupleurum falcatum, on alcohol binge-like drinking in rodents.
   Am J Drug Alcohol Abuse. 2026;52:33-41.
   PubMed     Abstract available
   
   
   September 2025
4. AREGBESHOLA BS, Paul C, Atorkey P, Dizon J, et al
   Factors associated with tobacco use, risky alcohol consumption, and concurrent tobacco and risky alcohol use among vocational education students.
   Am J Drug Alcohol Abuse. 2025 Sep 30:1-11. doi: 10.1080/00952990.2025.2547714.
   PubMed     Abstract available
   
   
   July 2025
5. SALOMON T, Gimenez PV, Nicolaides S, Cremonte M, et al
   The challenge of unrecorded alcohol consumption in Argentina: estimation and key predictors.
   Am J Drug Alcohol Abuse. 2025 Jul 28:1-8. doi: 10.1080/00952990.2025.2528774.
   PubMed     Abstract available
   
   
   June 2025
6. BULUMAC AL, Lazar F
   Benefits of Alcoholics Anonymous affiliation among meeting attendees in Romania: a mixed methods approach.
   Am J Drug Alcohol Abuse. 2025 Jun 23:1-12. doi: 10.1080/00952990.2025.2509106.
   PubMed     Abstract available
   
   
   March 2025
7. ELLIOTT GO, Petrie GN, Kroll SL, Roche DJO, et al
   Changes in peripheral endocannabinoid levels in substance use disorders: a review of clinical evidence.
   Am J Drug Alcohol Abuse. 2025;51:152-164.
   PubMed     Abstract available
   
   
   January 2025
8. KIRSCH DE, Belnap MA, Kady A, Ray LA, et al
   A narrative review on alcohol use in women: insight into the telescoping hypothesis from a biopsychosocial perspective.
   Am J Drug Alcohol Abuse. 2025;51:14-30.
   PubMed     Abstract available
   
   
   
9. HALL OT, Gunawan T, Teater J, Bryan C, et al
   Withdrawal interference scale: a novel measure of withdrawal-related life disruption in opioid use disorder and alcohol use disorder.
   Am J Drug Alcohol Abuse. 2025;51:44-56.
   PubMed     Abstract available
   
   
   
10. ZHANG J, Shen Y, Xiong S, Mou W, et al
    HIF-1alpha/miR-185 axis regulates lipid accumulation and metabolism involved in alcohol-related liver disease in mice.
    Am J Drug Alcohol Abuse. 2025;51:438-446.
    PubMed     Abstract available
    
    
    
11. ZHANG J, Mou W, Chen S, Wu Z, et al
    Regulation of HDL metabolism in alcohol-associated liver disease: the role of HIF-1alpha and miR-185 in SR-BI suppression.
    Am J Drug Alcohol Abuse. 2025;51:447-457.
    PubMed     Abstract available
    
    
    
12. BROCKDORF AN, Baildon AE, Gervais SJ, DiLillo D, et al
    Alcohol administration in studies of human aggression: a methodological review.
    Am J Drug Alcohol Abuse. 2025;51:395-412.
    PubMed     Abstract available
    
    
    
13. RATHORE BS, Singh S, Gupta M, Verma P, et al
    Safety and efficacy of ketamine for the treatment of patients with alcohol use disorder: a systematic review.
    Am J Drug Alcohol Abuse. 2025;51:563-576.
    PubMed     Abstract available
    
    
    
14. GRANT P, Sorkhou M, Ryan J, George TP, et al
    Sex and gender differences in co-occurring substance use and depressive disorders: a systematic review.
    Am J Drug Alcohol Abuse. 2025;51:687-707.
    PubMed     Abstract available
    
    
    
15. RICHARDSON RS, Farokhnia M, Vendruscolo LF, Leggio L, et al
    Plasma concentrations of the inflammatory adipokine lipocalin-2 are not affected by chronic alcohol exposure in rats or acute alcohol administration in people with alcohol use disorder.
    Am J Drug Alcohol Abuse. 2025;51:730-740.
    PubMed     Abstract available
    
    
    
16. GOMEZ R, Zarate D, Brown T
    The alcohol use disorders identification test (AUDIT): factor structure, test-retest reliability and longitudinal measurement invariance across a one-year interval in an Australian sample.
    Am J Drug Alcohol Abuse. 2025;51:708-716.
    PubMed     Abstract available
    
    
    
17. LOPEZ KM, Mancero-Montalvo R, Iturralde-Carrillo A, Feng A, et al
    Impact of acute binge-like ethanol exposure during the third-trimester equivalent on subicular interneurons in mice.
    Am J Drug Alcohol Abuse. 2025;51:717-729.
    PubMed     Abstract available
    
    
    November 2024
18. FILOMENA VELANDIA D, Aranda Rodriguez E, Garrido Albaina A, Clotas C, et al
    "I drink less and that's no small matter": a qualitative descriptive study of a managed alcohol program evaluation in Barcelona.
    Am J Drug Alcohol Abuse. 2024;50:841-850.
    PubMed     Abstract available
    
    
    
19. OLIVARES-COSTA M, Fabio MC, De la Fuente-Ortega E, Haeger PA, et al
    New therapeutics for the prevention or amelioration of fetal alcohol spectrum disorders: a narrative review of the preclinical literature.
    Am J Drug Alcohol Abuse. 2024;50:749-770.
    PubMed     Abstract available
    
    
    September 2024
20. CHEN Z, Ding C, Chen K, Lu C, et al
    Exploring the impact of inflammatory cytokines on alcoholic liver disease: a Mendelian randomization study with bioinformatics insights into potential biological mechanisms.
    Am J Drug Alcohol Abuse. 2024 Sep 25:1-16. doi: 10.1080/00952990.2024.2402569.
    PubMed     Abstract available
    
    
    
21. GONZALEZ-PONCE BM, Pilatti A, Rivarola Montejano G, Bravo AJ, et al
    Psychometric properties and Longitudinal Measurement Invariance of the Spanish version of the Alcohol Expectancies Questionnaire Short Form among young adult binge drinkers.
    Am J Drug Alcohol Abuse. 2024;50:631-642.
    PubMed     Abstract available
    
    
    July 2024
22. LAPE EC, Paladino MB, Powers JM, LaRowe LR, et al
    Awareness of the potential consequences of alcohol consumption in the context of chronic pain and prescription opioid use.
    Am J Drug Alcohol Abuse. 2024 Jul 30:1-8. doi: 10.1080/00952990.2024.2375515.
    PubMed     Abstract available
    
    
    
23. MILOSLAVICH K, Wardle M
    Anger is more strongly associated with alcohol and tobacco use and use disorders compared to other substances in American adults.
    Am J Drug Alcohol Abuse. 2024;50:433-441.
    PubMed     Abstract available
    
    
    
24. HARTWELL EE, Schwandt M, Nunez YZ, Wetherill RR, et al
    Identifying neurofunctional domains across substance use disorders.
    Am J Drug Alcohol Abuse. 2024;50:536-546.
    PubMed     Abstract available
    
    
    
25. GHOSH A, Morgan N, Calvey T, Scheibein F, et al
    Effectiveness of psychosocial interventions for alcohol use disorder: a systematic review and meta-analysis update.
    Am J Drug Alcohol Abuse. 2024;50:442-454.
    PubMed     Abstract available
    
    
    June 2024
26. JAMES SA, Chen S, Dang JH, Hall S, et al
    Changes in alcohol consumption and binge drinking during the COVID-19 pandemic among American Indians residing in California and Oklahoma.
    Am J Drug Alcohol Abuse. 2024 Jun 6:1-11. doi: 10.1080/00952990.2024.2344482.
    PubMed     Abstract available
    
    
    
27. SHAH PM, Pillarella NR, Telatin M, Negroni NC, et al
    Alcohol withdrawal and amphetamine co-use in an animal model for attention deficit hyperactivity disorder.
    Am J Drug Alcohol Abuse. 2024 Jun 4:1-11. doi: 10.1080/00952990.2024.2349885.
    PubMed     Abstract available
    
    
    March 2024
28. DIAZ LA, Arab JP, Leggio L
    Granulocyte-colony stimulating factor use in alcohol-associated hepatitis: is it time to promote liver regeneration?
    Am J Drug Alcohol Abuse. 2024;50:128-131.
    PubMed    
    
    
    
29. JETT JD, Beck R, Tyutyunnyk D, Sanchez J, et al
    Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial.
    Am J Drug Alcohol Abuse. 2024;50:162-172.
    PubMed     Abstract available
    
    
    
30. LIU R, Zhao B, Zhao J, Zhang M, et al
    Ethanol causes non-communicable disease through activation of NLRP3 inflammasome: a review on mechanism of action and potential interventions.
    Am J Drug Alcohol Abuse. 2024;50:139-149.
    PubMed     Abstract available
    
    
    January 2024
31. BU YL, Wang C, Zhao C, Lu X, et al
    The association of alcohol consumption with the risk of sarcopenia: a dose-response meta-analysis.
    Am J Drug Alcohol Abuse. 2024 Jan 17:1-16. doi: 10.1080/00952990.2023.2300049.
    PubMed     Abstract available
    
    
    
32. WARD S, Autaubo J, Waters P, Garrett E, et al
    A scoping review of health inequities in alcohol use disorder.
    Am J Drug Alcohol Abuse. 2024;50:27-41.
    PubMed     Abstract available
    
    
    
33. YALNIZ Y, Yunusoglu O, Berkoz M, Demirel ME, et al
    Effects of fisetin on ethanol-induced rewarding properties in mice.
    Am J Drug Alcohol Abuse. 2024;50:75-83.
    PubMed     Abstract available
    
    
    December 2023
34. HU A, Zhao X, Room R, Hao W, et al
    The effects of alcohol tax policies on alcohol consumption and alcohol use disorders in Mainland of China: an interrupted time series analysis from 1961-2019.
    Am J Drug Alcohol Abuse. 2023 Dec 7:1-10. doi: 10.1080/00952990.2023.2280948.
    PubMed     Abstract available
    
    
    November 2023
35. DUAN F, Liu C, Chang C, Song S, et al
    Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis.
    Am J Drug Alcohol Abuse. 2023 Nov 27:1-16. doi: 10.1080/00952990.2023.2266117.
    PubMed     Abstract available
    
    
    
36. SANZ J, Hernandez-Martinez T, Castillo-Burgos P, Sanz-Garcia A, et al
    Prevalence of increased alcohol use and alcohol use disorders in adult victims of terrorist attacks: a systematic and meta-analytic review.
    Am J Drug Alcohol Abuse. 2023;49:705-722.
    PubMed     Abstract available
    
    
    
37. ROUDEBUSH M, Godbole A, Johnson L, Egan KL, et al
    Alcohol protective behavioral strategies for young adults: a content analysis across drinking contexts and gender.
    Am J Drug Alcohol Abuse. 2023;49:818-826.
    PubMed     Abstract available
    
    
    
38. GHOSH A, Singh GK, Yadav N, Singh P, et al
    Brief interventions for alcohol misuse among people living with HIV: a meta-analysis.
    Am J Drug Alcohol Abuse. 2023;49:766-786.
    PubMed     Abstract available
    
    
    
39. HAVLIK JL, Rhee TG, Rosenheck RA
    Characterization of quality of life among individuals with current treated, untreated, and past alcohol use disorder.
    Am J Drug Alcohol Abuse. 2023;49:787-798.
    PubMed     Abstract available
    
    
    September 2023
40. LIAO J, Allen JH, Yorke M, Boettiger CA, et al
    Family history, childhood maltreatment, and adolescent binge drinking exert synergistic effects on delay discounting and future alcohol use.
    Am J Drug Alcohol Abuse. 2023;49:652-663.
    PubMed     Abstract available
    
    
    June 2023
41. XU WH, Li XH, Yu NJ, Tang Z, et al
    Comparison of the imaging and clinical characteristics between Initial and Recurrent Alcoholic Acute Pancreatitis: a retrospective cross-sectional study.
    Am J Drug Alcohol Abuse. 2023 Jun 27:1-9. doi: 10.1080/00952990.2023.2211221.
    PubMed     Abstract available
    
    
    May 2023
42. LOPEZ STEINMETZ LC, Leyes CA, Fong SB, Godoy JC, et al
    Alcohol consumption, alcohol expectancies, and drinking contexts in young Argentinean college students before and during the COVID-19 pandemic: a one-year follow-up study.
    Am J Drug Alcohol Abuse. 2023 May 16:1-11. doi: 10.1080/00952990.2023.2192376.
    PubMed     Abstract available
    
    
    
43. GANO A, Deak T, Pautassi RM
    A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse.
    Am J Drug Alcohol Abuse. 2023;49:269-282.
    PubMed     Abstract available
    
    
    
44. NIEDZWIEDZ-MASSEY VM, Douglas JC, Rafferty T, Johnson JW, et al
    Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation.
    Am J Drug Alcohol Abuse. 2023;49:345-358.
    PubMed     Abstract available
    
    
    
45. GRODIN EN, Meredith LR, Burnette EM, Miotto K, et al
    Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study.
    Am J Drug Alcohol Abuse. 2023;49:333-344.
    PubMed     Abstract available
    
    
    
46. PEREZ-REYTOR D, Karahanian E
    Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment.
    Am J Drug Alcohol Abuse. 2023;49:283-289.
    PubMed     Abstract available
    
    
    March 2023
47. HOLLAND AL, Sharma P, Kurani S, Pazdernik V, et al
    Longitudinal factors associated with increased alcohol consumption in adults during the COVID-19 pandemic.
    Am J Drug Alcohol Abuse. 2023 Mar 7:1-10. doi: 10.1080/00952990.2023.2176236.
    PubMed     Abstract available
    
    
    
48. HALLGREN KA, Galloway GP, Witkiewitz K, Linde P, et al
    Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder.
    Am J Drug Alcohol Abuse. 2023;49:249-259.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alcoholism is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum